Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role?
Authors
Keywords
NSCLC, Electrochemotherapy, Immunotherapy, Immunomodulators PD-1 CTLA-4
Journal
CANCER AND METASTASIS REVIEWS
Volume 34, Issue 1, Pages 129-144
Publisher
Springer Nature
Online
2015-02-28
DOI
10.1007/s10555-015-9550-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LBA43ANTITUMOR ACTIVITY OF PEMBROLIZUMAB (PEMBRO; MK-3475) AND CORRELATION WITH PROGRAMMED DEATH LIGAND 1 (PD-L1) EXPRESSION IN A POOLED ANALYSIS OF PATIENTS (PTS) WITH ADVANCED NON–SMALL CELL LUNG CARCINOMA (NSCLC)
- (2017) E.B. Garon et al. ANNALS OF ONCOLOGY
- Electrochemotherapy: from the drawing board into medical practice
- (2014) Damijan Miklavčič et al. Biomedical Engineering Online
- TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non-Small Cell Lung Cancer
- (2014) S. Chatterjee et al. CANCER RESEARCH
- New Strategies in Lung Cancer: Translating Immunotherapy into Clinical Practice
- (2014) Patrick M. Forde et al. CLINICAL CANCER RESEARCH
- Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes
- (2014) Ching-Yao Yang et al. EUROPEAN JOURNAL OF CANCER
- Combination therapy with ipilimumab and electrochemotherapy: preliminary efficacy results and correlation with immunological parameters
- (2014) Ester Simeone et al. Journal of Translational Medicine
- Immunotherapy in the treatment of non-small cell lung cancer
- (2014) Raghav Sundar et al. LUNG CANCER
- Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells
- (2014) Christophe Y Calvet et al. OncoImmunology
- Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab
- (2013) Jeffrey S. Weber et al. CANCER
- Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours
- (2013) Saleem Jahangeer et al. CANCER TREATMENT REVIEWS
- Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer
- (2013) Yuan Yuanying et al. CRYOBIOLOGY
- Severe acute respiratory distress syndrome due to ipilimumab
- (2013) Daniel Franzen et al. EUROPEAN RESPIRATORY JOURNAL
- Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma
- (2013) Jiuwei Cui et al. INTERNATIONAL JOURNAL OF CANCER
- Programmed death ligand-1 expression in non-small cell lung cancer
- (2013) Vamsidhar Velcheti et al. LABORATORY INVESTIGATION
- Sweet’s syndrome in a patient with metastatic melanoma after ipilimumab therapy
- (2013) Sofya Pintova et al. MELANOMA RESEARCH
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential Mechanisms Associated with Vascular Disrupting Action of Electrochemotherapy: Intravital Microscopy on the Level of Single Normal and Tumor Blood Vessels
- (2013) Bostjan Markelc et al. PLoS One
- Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer
- (2013) Li-Zhi Niu WORLD JOURNAL OF GASTROENTEROLOGY
- Immune Checkpoint Inhibitors: Making Immunotherapy a Reality for the Treatment of Lung Cancer
- (2013) J. R. Brahmer et al. Cancer Immunology Research
- Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
- (2013) M. J. Selby et al. Cancer Immunology Research
- Electrochemotherapy for large cutaneous recurrence of breast cancer: A phase II clinical trial
- (2012) Louise Wichmann Matthiessen et al. ACTA ONCOLOGICA
- Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence
- (2012) Michael Lanuti et al. ANNALS OF THORACIC SURGERY
- The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study
- (2012) Luca G. Campana et al. BREAST CANCER RESEARCH AND TREATMENT
- Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer
- (2012) Sandra Salvi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Direct Therapeutic Applications of Calcium Electroporation to Effectively Induce Tumor Necrosis
- (2012) S. K. Frandsen et al. CANCER RESEARCH
- Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy
- (2012) Gianni Gerlini et al. CLINICAL & EXPERIMENTAL METASTASIS
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
- (2012) Suzanne L Topalian et al. CURRENT OPINION IN IMMUNOLOGY
- MECHANISMS IN ENDOCRINOLOGY: Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review
- (2012) A. Juszczak et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
- (2012) Thomas J. Lynch et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy
- (2012) Mette Linnert et al. Radiology and Oncology
- Electrochemotherapy of cutaneous metastastes from breast cancer in elderly patients: a preliminary report
- (2012) Raffaella Benevento et al. BMC Surgery
- Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation
- (2012) Gianni Gerlini et al. OncoImmunology
- Management of cutaneous metastases using electrochemotherapy
- (2011) Louise Wichmann Matthiessen et al. ACTA ONCOLOGICA
- Patient Responses to Ipilimumab, a Novel Immunopotentiator for Metastatic Melanoma
- (2011) Gregory K. Pennock et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase Ⅰ clinical study of combination therapy with microwave ablation and cellular immunotherapy in hepatocellular carcinoma
- (2011) Pei Zhou et al. CANCER BIOLOGY & THERAPY
- Anti-TIM3 Antibody Promotes T Cell IFN- -Mediated Antitumor Immunity and Suppresses Established Tumors
- (2011) S. F. Ngiow et al. CANCER RESEARCH
- Preclinical Validation of Electrochemotherapy as an Effective Treatment for Brain Tumors
- (2011) B. Agerholm-Larsen et al. CANCER RESEARCH
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Electrochemotherapy of chest wall breast cancer recurrence
- (2011) Gregor Sersa et al. CANCER TREATMENT REVIEWS
- Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
- (2011) Caicun Zhou et al. LANCET ONCOLOGY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Revised RECIST Guideline Version 1.1: What Oncologists Want to Know and What Radiologists Need to Know
- (2010) Mizuki Nishino et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) G. D'Addario et al. ANNALS OF ONCOLOGY
- Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
- (2010) S. J. O'Day et al. ANNALS OF ONCOLOGY
- Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) L. Crino et al. ANNALS OF ONCOLOGY
- B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
- (2010) J.-J. Park et al. BLOOD
- Natural killer cells and cancer: Regulation by the killer cell Ig-like receptors (KIR)
- (2010) Amanda K. Purdy et al. CANCER BIOLOGY & THERAPY
- CD73: A Novel Target for Cancer Immunotherapy
- (2010) B. Zhang CANCER RESEARCH
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Endpoints for Cancer Immunotherapy Trials
- (2010) A. Hoos et al. JNCI-Journal of the National Cancer Institute
- High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
- (2010) Chuan-Yong Mu et al. MEDICAL ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Emerging Toxicity Profiles of Anti–CTLA-4 Antibodies Across Clinical Indications
- (2010) Anna Maria Di Giacomo et al. SEMINARS IN ONCOLOGY
- Image-Guided Radiofrequency Ablation of Lung Neoplasm in 100 Consecutive Patients by a Thoracic Surgical Service
- (2009) Arjun Pennathur et al. ANNALS OF THORACIC SURGERY
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma
- (2009) J. Weber et al. CLINICAL CANCER RESEARCH
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- (2009) Karl S. Peggs et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Systematic Review of Radiofrequency Ablation for Lung Tumors
- (2008) Jacqui C. Zhu et al. ANNALS OF SURGICAL ONCOLOGY
- Epitope Landscape in Breast and Colorectal Cancer
- (2008) N. H. Segal et al. CANCER RESEARCH
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapeutic Drugs may be Used to Enhance the Killing Efficacy of Human Tumor Antigen Peptide-specific CTLs
- (2008) Pierpaolo Correale et al. JOURNAL OF IMMUNOTHERAPY
- Radiofrequency ablation for treatment of medically inoperable stage I non–small cell lung cancer
- (2008) Michael Lanuti et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- The Mechanism of Anti-CTLA-4 Activity and the Negative Regulation of T-Cell Activation
- (2008) J. D. Wolchok et al. ONCOLOGIST
- Microwave Ablation of Lung Malignancies: Effectiveness, CT Findings, and Safety in 50 Patients
- (2008) Farrah J. Wolf et al. RADIOLOGY
- Electrochemotherapy in treatment of tumours
- (2007) G. Sersa et al. EJSO
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started